Literature DB >> 2760797

Facilitated transport of benzylpenicillin through the blood-brain barrier in rats.

H Suzuki1, Y Sawada, Y Sugiyama, T Iga, M Hanano.   

Abstract

The unidirectional influx of benzylpenicillin through the blood-brain barrier was examined with an in situ rat brain perfusion technique using purified [3H]benzylpenicillin. The major transport system of benzylpenicillin through the blood-brain barrier was via a saturable process with a one-half saturation concentration of approximately 8-30 microM. This transport system was significantly inhibited by probenecid (100 microM) and ceftriaxone (2 mM), indicating that the transport system may be shared by some organic anions including third generation cephalosporin antibiotics. These findings suggest that concomitant administration of beta-lactam antibiotics could produce a drug interaction to alter the drug penetration into the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2760797     DOI: 10.1248/bpb1978.12.182

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  4 in total

Review 1.  Active efflux across the blood-brain barrier: role of the solute carrier family.

Authors:  Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  NeuroRx       Date:  2005-01

2.  beta-lactam antibiotics in the treatment of neuroborreliosis in children: preliminary results.

Authors:  M M Millner; G H Thalhammer; P Dittrich; K D Spork; M Brunner; A Georgopoulos
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

3.  Development of a physiologically-based pharmacokinetic model of the rat central nervous system.

Authors:  Raj K Singh Badhan; Marylore Chenel; Jeffrey I Penny
Journal:  Pharmaceutics       Date:  2014-03-18       Impact factor: 6.321

4.  Development of a Region-Specific Physiologically Based Pharmacokinetic Brain Model to Assess Hippocampus and Frontal Cortex Pharmacokinetics.

Authors:  Zaril Zakaria; Raj Badhan
Journal:  Pharmaceutics       Date:  2018-01-17       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.